Skip to main content

Table 2 Muscle activation pattern (%MVC) during SLR neurodynamic testing

From: Mechanosensitivity during lower extremity neurodynamic testing is diminished in individuals with Type 2 Diabetes Mellitus and peripheral neuropathy: a cross sectional study

  

PF/SLR

DF/SLR

Muscle

Resting

Start

P1

P2

Start

P1

P2

Soleus

20.2 ± 16.1

19.9 ± 15.7

21.3 ± 16.6†

21.7 ± 16.3

20.7 ± 17.4

23.0 ± 19.5†

22.6 ± 16.7

Medial gastrocnemius

14.6 ± 13.6

16.0 ± 15.2

18.9 ± 19.3

20.2 ± 21.5

16.8 ± 16.2

19.4 ± 20.77

19.9 ± 18.0

Tibialis anterior

5.3 ± 4.1

5.2 ± 4.3†

5.7 ± 5.5†

6.3 ± 6.9†

9.7 ± 8.9 *†

9.0 ± 8.0 *†

9.4 ± 10.1 *†

Vastus medialis

13.8 ± 12.2

13.9 ± 12.9†

16.3 ± 14.9

16.5 ± 14.0

9.9 ± 7.6†

15.7 ± 14.1

15.6 ± 12.9

Rectus femoris

11.8 ± 7.8

12.4 ± 10.1

14.8 ± 14.7

15.9 ± 13.1†

12.6 ± 9.7

13.4 ± 9.9

14.2 ± 9.6†

Semitendinosus

9.3 ± 8.3

9.7 ± 9.0

10.6 ± 9.0

12.4 ± 9.1

9.6 ± 9.5

11.3 ± 9.5

12.7 ± 9.9

Biceps femoris

9.3 ± 6.1

10.4 ± 7.1†

11.2 ± 7.9

13.5 ± 8.8

9.1 ± 6.3†

13.3 ± 17.4

13.4 ± 9.4

Gluteus maximus

28.4 ± 21.0

28.2 ± 23.3

31.6 ± 26.9

36.0 ± 29.2

28.8 ± 22.6

34.8 ± 43.8

38.9 ± 36.1

  1. * denotes statistically significant increase of greater than 1.5x "Resting" levels for general linear model of repeated measures for within test differences.
  2. † denotes statistically significant difference between PF/SLR and DF/SLR tests using paired t-test comparison for "Start" and "P1" and "P2."